Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.
about
Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer's disease: a tale of shotgun lipidomicsSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceAPOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure.Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease.The complex interaction between APOE promoter and AD: an Italian case-control studyApolipoproteins in the brain: implications for neurological and psychiatric disorders.Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease.Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease.Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptidesThe importance of brain banks for molecular neuropathological research: The New South Wales Tissue Resource Centre experienceTranscriptional regulation and its misregulation in Alzheimer's disease.Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease.Association between subjective memory assessment and associative memory performance: Role of ad risk factors.Neurodegenerative Genes Polymorphisms of the -491A/T APOE, the -877T/C APP and the Risk of Primary Open-angle Glaucoma in the Polish Population.
P2860
Q28256439-84B2D4AD-3758-4E94-9E09-DC4922396788Q29618819-B370634E-6767-4C1F-A52F-EE2C4CA822E5Q33691358-66C176AC-E725-44F1-A960-C1C994084A27Q33915435-CDDF178E-3E61-4600-9346-983F3FBD65D7Q34326720-047C9DEC-807C-42CB-8CD8-55B3006FE728Q34680878-89A03251-DC1D-46E2-B076-7958F0D62DEBQ35337926-86CA2588-A59B-4019-A188-C6E54D0394A1Q35444823-41A2B180-2F63-40B9-AB89-EA56DF937554Q35488917-221D7684-2FC4-4E0B-9D3A-F335E5648288Q35607880-BB60850A-79D6-47CE-A24E-E319CDEA3B6FQ36386913-C94A7D23-6208-4141-B1EC-12D3A3243048Q37143169-97120027-00A0-4F5F-932D-6BAF6EEEC2C4Q37370537-6B4D3FE7-7B90-4A78-B307-60DB5FB47F8CQ40621541-CBC1989C-546E-46BE-B55C-D7C9759B04C5Q50533465-5698D078-CC88-4606-B962-84C0693EDD9EQ54241703-CB4269EE-7870-4A20-AB9E-94B9D2439EB2
P2860
Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Variation at the APOE -491 pro ...... in levels of apolipoprotein E.
@en
Variation at the APOE -491 pro ...... in levels of apolipoprotein E.
@nl
type
label
Variation at the APOE -491 pro ...... in levels of apolipoprotein E.
@en
Variation at the APOE -491 pro ...... in levels of apolipoprotein E.
@nl
prefLabel
Variation at the APOE -491 pro ...... in levels of apolipoprotein E.
@en
Variation at the APOE -491 pro ...... in levels of apolipoprotein E.
@nl
P2093
P2860
P356
P1433
P1476
Variation at the APOE -491 pro ...... in levels of apolipoprotein E.
@en
P2093
Lautenschlager N
Martins RN
P2860
P2888
P304
P356
10.1038/SJ.MP.4001097
P407
P577
2002-01-01T00:00:00Z